The World Health Organization has recommended steroid medications to treat severe cases of Coronavirus after studies showed steroids could reduce the risk of death for hospitalized patients on ventilators by about a third.
Among all the patients, there were 222 deaths among the 678 patients who received corticosteroids, and 425 deaths among the 1,025 patients randomized to usual care or placebo.
"This reduction is relevant in the context of a pandemic, in which an low-cost, safe, and widely available intervention like dexamethasone increases even modestly the number of ventilator-free days and may reduce the risk of ventilatory complications, ICU length of stay, and burden to the health care system", the group concluded.
Treatment guidelines in the US now recommend dexamethasone or other only when it's not available for hospitalized COVID-19 patients needing extra oxygen, but that could change with new information.More news: Honor Watch GS and Honor Watch ES launched at IFA 2020
Covid cases continued to surge in the capital, with 2,914 cases being recorded on Friday.
Overall, "these trial results from diverse clinical and geographical settings suggest that in the absence of compelling contraindications, a corticosteroid regimen should be a component of standard care for critically ill patients with COVID-19", Sterne's group concluded.
In June, preliminary results of the RECOVERY trial, published in a peer-reviewed paper, were released.
Initially, the use of these drugs in COVID-19 was controversial.More news: Coronavirus: Scuffles at anti-lockdown protest in Melbourne
That advance was great news, but those findings created a conundrum for Angus and other researchers who were running their own studies of steroids in COVID-19 patients.
The state government also fixed the maximum charges to be taken from patients who will be kept in these extended COVID care centres in three different categories of hotels- high class, medium class and standard class. As Prescott and Rice explained, these drugs work to counter the runaway inflammatory response - the so-called "cytokine storm" - that can drive late-stage COVID-19 and overwhelm patients' defenses. The non-NABH accredited hospitals can charge Rs 6,200, Rs 10,000 and Rs 14,000 from moderate, severe and very severely ill patients, respectively, he said. The drugs are steroids, and the research published Wednesday confirms they are proving to be the most effective treatment found to date.
Steroids help tamp down the immune system's potentially deadly overreaction to an infection.
By the end of Saturday, a total of 2,573 imported cases had been reported on the mainland.More news: Jadeveon Clowney Expected To Sign With Titans